INSIGHTS ON DOWNSTREAM MANUFACTURING
-
Designing ADC Manufacturing For Operator And Patient Safety
ADC manufacturing succeeds when manufacturability is treated as an early design input. Cell line choices, toxic payload handling, and single-use extractables each shape operator exposure and risk.
-
Advancing Downstream Bioprocessing With Single-Use Solutions
Closed, configurable single-use fluid management between downstream steps can influence how flexible, efficient, and agile a bioprocess is, from early development through commercial production.
-
The Critical Role Of Integrated Handling Design
Unplanned downtime and inconsistent throughput on syringe and injectable lines often trace back to handling design. System-level thinking about transport changes where performance is decided.
-
Rethinking Facility Design For The Reality Of Complex Biologics
Inert surface technologies reduce metal-related adsorption in chromatography, improving peak shape, recovery, sensitivity, and quantitation for more reliable analytical results.
-
How Automation Can Facilitate Annex 1 Compliance In Final Filtration11/3/2026
Annex 1 expectations for PUPSIT expose how much risk sits in operator-dependent final filtration, and why automation, assembly design, and product recovery now shape compliance decisions.
-
Simtra Biopharma Solutions Capabilities Update October 2026: Fill Finish11/3/2026
Explore new sterile manufacturing capacity for pre-filled syringes, lyophilized vials, and potent therapies, supporting flexibility, scale, and supply resilience.
-
Alcami Capabilities Update October 2026: Fill Finish11/3/2026
Discover critical considerations for sterile fill-finish, including manufacturability, scale-up, contamination control, and the path from clinical to commercial supply.
-
Advances In ADC Development And Manufacturing11/3/2026
ADC manufacturability starts at molecule design, not downstream rescue. Learn how operator exposure to high-potency payloads shapes how conjugation workflows are built and qualified.
-
The People Behind The Process: How Teams Enable Flexible Manufacturing11/2/2026
Biopharma demands flexibility across specialty and high-volume products. The right equipment, automation, and teams enable partners to pivot without compromising quality.
DOWNSTREAM MANUFACTURING SOLUTIONS
-
North American biologics manufacturing supports programs from drug substance through fill/finish, device assembly, and cold-chain logistics, backed by 10+ years of regulatory inspections.
-
Discover how one modular platform handles both prep HPLC and FPLC, and what it takes to carry purification methods from milligram bench work to pilot-scale runs with shared software.
-
Single-use chromatography at process scale, rebuilt around faster flow kit installation, barcode-driven batch records, and simpler automation connectivity, with a smaller manufacturing footprint.
-
The ÄKTA ready™ chromatography system has been redesigned as the SCS (standard configuration system) platform to meet current and future needs for batch manufacturing and intensified processing. SCS systems retain the benefits of single-use processing, with one-piece disposable flow paths that allow quick changeover and reduce the risk of carryover, while eliminating the need for cleaning between runs. The next-generation system is designed to improve usability for operators of all skill levels and to remove friction in your manufacturing process.
-
Variability in column care and buffer preparation grows as biologics processes scale. Defined, ready-to-use solutions support reproducibility across purification workflows and manufacturing scale-up.